Legend Biotech (LEGN)

• Market cap: $3.51B
• 1 day: -1.45%
• 5 days: -9.82%
• 1 month: 4%
• 3 months: -31.43%
• 6 months: -45.28%
• Year to date: -11.67%
• 1 year: -48.26%
• 5 years: -28.11%
• 10 years: -48.65%
• Sector: Healthcare
• Industry: Biotechnology

About: Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Employees: 2,900